Turnstone Biologics Corp. (TSBX)

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Therapeutics	19.31M	Log In	Log In
Therapeutics Growth	-73.66%	Log In	Log In

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
United States	19.31M	Log In	Log In
United States Growth	-73.66%	Log In	Log In